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Protein energy malnutrition predicts complications in liver
cirrhosis
Ellen J. Huisman, Evelien J. Trip, Peter D. Siersema, Bart van Hoek
and Karel J. van Erpecum
Background Protein energy malnutrition frequently
occurs in liver cirrhosis. Hand-grip strength according to
Jamar is most reliable to predict protein energy
malnutrition. We aimed to determine whether protein
energy malnutrition affects complication risk.
Methods In 84 cirrhotics, baseline nutritional state was
determined and subsequent complications prospectively
assessed. Influence of potentially relevant factors including
malnutrition (by Jamar hand-grip strength) on complication
rates were evaluated with univariate analysis. Effect of
malnutrition was subsequently evaluated by multivariate
logistic regression with adjustment for possible
confounders.
Results Underlying causes of cirrhosis were viral hepatitis
in 31%, alcohol in 26%, and other in 43%. Baseline
Child–Pugh (CP) class was A, B, or C in 58, 35, and 7%,
respectively. Energy and protein intake decreased
significantly with increasing CP class, with shift from
proteins to carbohydrates. At baseline, according to Jamar
hand-grip strength, malnutrition occurred in 67% (n = 56).
Malnutrition was associated with older age and higher CP
class (CP class A 57%, B 79%, C 100%) but not with
underlying disease or comorbidity. Complications occurred
in 18 and 48% in well-nourished and malnourished
patients, respectively, (P = 0.007) during 13 ± 6 months
follow-up. In multivariate analysis, malnutrition was an
independent predictor of complications, after correcting for
comorbidity, age, and CP score (adjusted odds ratio 4.230;
95% confidence interval 1.090–16.422; P = 0.037). In
univariate analysis, mortality (4 vs. 18%; P = 0.1) tended to
be worse in malnourished patients, but this trend was lost
in multivariate analysis.
Conclusion Malnutrition is an independent predictor of
complications in cirrhosis. Eur J Gastroenterol Hepatol
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Introduction
Protein-energy malnutrition (PEM) is a frequent phe-
nomenon in liver cirrhosis, occurring in 20% of patients
with compensated cirrhosis and in 60% or more of
patients with decompensated cirrhosis [1,2]. PEM may
develop in the early phase of cirrhosis [3], regardless of
the underlying cause of the liver disease [4]. Its
pathogenesis is multifactorial: major contributing factors
are inadequate dietary intake, maldigestion, and malab-
sorption of both macronutrients and micronutrients and
abnormal substrate utilization. In addition, reduced
synthesis and increased loss of protein specifically
contribute to the pathogenesis of PEM [5]. PEM is
associated with impaired immunity, especially in ad-
vanced liver disease. This may increase risk of infection in
this patient category with underlying intestinal bacterial
overgrowth and impaired intestinal barrier function [6,7].
PEM could also increase risk of other complications, such
as variceal bleeding, ascites, encephalopathy, and hepa-
torenal syndrome [8,9]. Furthermore, the nutritional
state may affect quality of life [10] and, after liver
transplantation, graft function and patient morbidity or
mortality [11].
Despite its importance, PEM is often underdiagnosed in
patients with cirrhosis [12], particularly in the early
stages of disease [13]. Fluid retention, obesity, or other
metabolic changes may interfere with diagnosing mal-
nutrition [14]. As a result, there is no easy and decisive
parameter for PEM in patients with cirrhosis [15].
Although controversial [16], hand-grip strength (HGS)
according to Jamar (reflecting muscle mass and therefore
protein status) is most often used to assess protein
depletion in cirrhotics [17–19]. Previous studies indi-
cated that Jamar HGS is highly sensitive but not very
specific to diagnose protein depletion [15]. In this study,
we aimed to (a) determine frequency of malnutrition in a
group of patients with liver cirrhosis of various etiologies
and in various stages of disease, with the aid of various
complementary methods including Jamar HGS, and (b)
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to assess in a prospective design, the effects of nutritional
state – in particular PEM – on occurrence of complica-
tions and survival in these patients.
Patients and methods
Patients
In this prospective study, inclusion criteria were the
presence of unequivocal cirrhosis based on a combination
of clinical, laboratory, radiologic (ultrasound, MRI scan,
computed tomographic scan, Fibroscan) and histologic
(liver biopsy) findings and patient consent to participate
in the baseline nutritional assessments and follow-up.
Exclusion criteria were previous liver transplant and
coexistent conditions that could affect nutritional state
(e.g. gastrointestinal tract disease, malignancy, HIV
positivity) and conditions interfering with determination
of nutritional state (e.g. mental retardation, arthritis or
other secondary diseases that could affect parameters of
nutritional state such as HGS). A total of 99 consecutive
patients with cirrhosis visiting the outpatient department
of two University Hospitals in the period June 2007–April
2008 were considered for inclusion. Fifteen patients with
cirrhosis were excluded because of baseline hepatocellular
carcinoma (HCC: n = 5) or pegylated-interferon-based
therapy planned during follow-up (n = 10), considering
the potential influence of these conditions on nutritional
state. In the remaining 84 patients, baseline dietary
history and nutritional state were determined in detail
with complementary single and combined parameters.
Patients visited the outpatient clinic at 6-month in-
tervals, or more frequently if indicated. Follow-up ended
in case of death, transplantation or time of final
evaluation. Laboratory tests determined at baseline and
at follow-up visits including liver synthetic parameters
(albumin, international normalized ratio, prothrombin
time), bilirubin and creatinine were determined by
standard methods. Complications which had occurred
before inclusion were noted. During follow-up, the
following complications were registered: new onset
ascites (diuretic responsive or refractory), hepatic en-
cephalopathy, esophageal bleeding, hepatorenal syn-
drome, spontaneous bacterial peritonitis, other bacterial
infections (like pneumonia or urinary tract infection),
and HCC. The occurrence of hepatic encephalopathy
was based on the Conn criteria as evaluated by the
physicians in care of the patient. All complications
weighed equally. Transplantation during follow-up was
also recorded.
Parameters of nutritional state
Baseline dietary intake was calculated by a specialized
nutritionist according to standard methods and compared
with the nutritional requirements recommended for
patients with liver cirrhosis in the ESPEN guidelines
from 2006 [20]. Height and weight were obtained with a
precision of 1 cm and 0.1 kg (Seca scale), respectively.
Fluid retention, ascites, encephalopathy, and other
parameters of clinical relevance were estimated by the
experienced hepatologist in care for the patient. Baseline
nutritional state was determined in detail with comple-
mentary single and combined parameters. Single para-
meters were (a) BMI corrected for fluid retention
(BMIc) [21]; (b) mid-arm muscle circumference
(MAMC) [22]; HGS according to (c) Jamar [17,18] or
according to (d) Citec. Combined parameters were (e)
body cell mass (BCM) [15] and (f) subjective global
assessment (SGA) according to Hasse et al. [23]. (a) BMIc
was calculated as estimated dry weight/(height)2 (in
kg/m2) [24]. BMIc cutoff values as suggested by Campillo
et al. [21] were used to indicate malnutrition. These
cutoff values are 22 kg/m2, 23 kg/m2, and 25 kg/m2 in
patients without, with mild, and with tense ascites,
respectively. (b) Mid-arm circumference (MAC) and
triceps skin fold thickness (TSF) were first measured to
the nearest millimeter at the nondominant arm with a
measurement tape and a skin fold calliper with a pressure
of 10 g/mm2 of contact surface (Holtain Ltd London,
UK). Measurements were taken midway between the tip
of the acromion and the olecranon process, with the
patient standing in a relaxed position. MAMC was then
calculated from MAC and TSF with the formula MAMC
= MAC – (pTSF). The average of three measure-
ments was used. Values of MAMC were compared with
those of a healthy reference population [22]. (c)
Voluntary HGS was measured in the dominant hand by
using a calibrated Jamar dynamometer (Biometrics,
Almere, The Netherlands) adjusted for sex, age, and
height and compared with a healthy reference popula-
tion [18]. The best of three consecutive measurements
was recorded (1 min recovery time between attempts).
(d) Pinch power (Citec) was assessed with a pinch gauge
(C.I.T. Technics, Centre for Innovative Technics, The
Netherlands) to test the isometric muscle strength (in
Newtons). Isometric strength is the torque generated by
a muscle group when it is not allowed to shorten during
contraction, the muscle being made to contract against an
immovable load. (e) BCM: Figueiredo et al. [15] found
that the combination of MAMC and HGS was the best
predictor of the BCM. The combined criteria of a HGS
less than 30 kg and a MAMC below 23 cm were reported
to exhibit a sensitivity of 94% and a negative predictive
value of 97% in identifying patients with a depleted
BCM [15]. (f) The SGA adjusted for patients with liver
cirrhosis by Hasse et al. [23]. This parameter comprises
weight loss during previous 6 months in combination with
changes in diet intake during the week before evaluation
and gastrointestinal symptoms, functional capacity and
fluid retention at the time point of evaluation. The
physical examination focuses on loss of subcutaneous fat,
muscle wasting and fluid retention. SGA is classified as
normal, mild, moderate or severe malnutrition. Based on
previous data [17–19], before the start of the study, we
chose baseline HGS according to Jamar to distinguish
well-nourished and malnourished patients.
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Quality of life survey
Quality of life was assessed using the validated Medical
Outcomes Study 36-item Short-Form General Health
Survey (SF-36) described in detail elsewhere [25]. The
SF-36 scale does not reflect symptoms particular to certain
conditions, but evaluates health comprehensively, and is
used for a wide variety of disorders. SF-36 scores range from
0 (lowest) to 100 (highest), with higher scores indicating
better health-related quality of life. The SF-36 is composed
of 36 questions, which provide a quantitative evaluation for
each of eight subscales: physical function, role–physical,
bodily pain, general health perceptions, vitality, social
function, role–emotional, and mental health (MH). The
survey contains four domains in the area of physical health
(physical function, role–physical, bodily pain, and general
health perceptions) and four in the area of MH (vitality,
social function, role–emotional, and MH). Raw scores were
transformed into 0–100 scales, with 0 and 100 assigned to
lowest and highest possible values, respectively. Higher
scores indicate better health. The scales of SF-36 were
summarized into two scales: the physical component
summary and the MH component summary.
Statistical analysis
Statistical analysis was carried out using SPSS version
15.0 for Windows. Data are given as mean ± SD in case of
parametric distribution and also as median and range in
case of nonparametric distribution. Differences were
tested for statistical analysis by dependent or indepen-
dent t-test, Pearson w2-test or analysis of variance with
Fisher LSD as post-hoc test as appropriate. The
Kolmogorov–Smirnov test was used to test for normal
distribution. The Mann–Whitney U test or the Kruskal–
Wallis test was used if the normality assumption was not
met. The primary endpoints were a complication or end
of follow-up.
Complications during follow-up were compared between
well-nourished and malnourished groups according to
Jamar HGS [17–19]. The influence of nutritional status
according to Jamar HGS, age, sex, underlying cause of
cirrhosis, comorbidity, CP score, and BMI score on
complications and mortality during follow-up were first
evaluated with univariate analysis using logistic regression.
As we were interested only in the effects of nutritional
state on complication risk, multivariate logistic regression
was subsequently used to adjust for possible confouders:
All variables with P-value of less than 0.200 in univariate
analysis were entered in the model as covariables. Back-
ward stepwise regression was then used to exclude
variables with P value of more than 0.05. Results of
logistic regression are presented as adjusted odds ratios
(OR) with exact 95% confidence intervals (CI) and two-
sided P-values. Differences between Kaplan–Meier curves
were tested for statistical significance using the log rank




Baseline characteristics of the 84 included patients are
given in Table 1. The underlying causes of cirrhosis were
viral hepatitis in 31%, alcohol in 26%, and other diseases
(autoimmune hepatitis, primary biliary cirrhosis, primary
sclerosing cholangitis, hemochromatosis, Wilson disease)
in 43% of cases. Baseline Child–Pugh (CP) class was A, B,
or C in 58, 35, and 7%, respectively. Forty-six percent of
the patients exhibited significant comorbidity (diabetes
mellitus, cardiovascular disease, inflammatory bowel
disease). Twenty-nine percent of patients were on the
waiting list for transplantation.
Nutritional assessment
Various parameters of nutritional status indicated mal-
nutrition in 5–74% of all cases depending on the method
used (Jamar 67%, Citec 74%, MAMC 58%, SGA 58%,
BCM 39%, BMIc 5%). For most methods, malnutrition
tended to be more freqent with higher CP class (Table 2).
At baseline, 67% of patients (n = 56) were malnourished
(CP class A 57%, B 79%, C 100%) and 33% (n = 28) well
nourished according to Jamar HGS. Of note, prevalence
of obesity was high in our Dutch patients with liver
cirrhosis, independent of CP class: 25% were overweight
[BMI overweight (BMIc 25–29.9), 14% were obese
(BMIc 30–34.9), 5% severely obese (BMIc 35–39.9),
and 1% morbidly obese (BMIc Z 40). Only 5% of
patients were severely underweight (below 18.5 kg/m2).
BMIc, according to cutoff values of Campillo et al. [21],
indicated malnutrition in 25% of cases.
At baseline assessment, energy, and protein intake were
found to be significantly lower with higher CP class. Most
importantly, this phenomenon was accompanied by a shift
from protein to carbohydrate intake (Table 2). CP class did
not significantly affect intake of vegetables, fruit or fiber.
Ratio of carbohydrate to protein intake as percentage of
total energy intake (energy %) was significantly higher with
more severe CP class, and was also associated with
malnutrition according to Jamar HGS (Tables 1 and 2).
No significant difference was found in the intake of fat
(energy %) between various CP classes or patients with or
without sufficient HGS according to Jamar (Tables 1 and 2).
Quality of life
The physical and mental components of the quality of life
(SF-36) tended to be lower with increasing disease
severity according to CP class without reaching signifi-
cance (Table 2). In malnourished patients according to
Jamar HGS, the physical component of the SF-36 was
significantly lower (P < 0.00001), whereas the mental
component tended to be lower (P = 0.066; Table 1).
HGS and complications
Of the six nutritional parameters used, only insufficient
Jamar HGS was an independent predictor of complications.
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Although in univariate analysis, there was a trend for SGA
and MAMC to predict complications, this trend was lost in
subsequent multivariate analysis. In the well-nourished
(n = 28, 33%) and malnourished (n = 56, 67%) groups
according to Jamar HGS, follow-up was 14 ± 3 months
and 12 ± 6 months, respectively (P = 0.049). Malnutrition
according to Jamar was associated with older age and higher
CP class but not with underlying disease or comorbidity
(Tables 1 and 2).
Of the 24 patients on transplant waiting list at baseline,
nine (38%) were transplanted during follow-up. During
follow-up, 32 patients experienced at least one new
complication. At least one complication occurred in 18%
and 48% of patients in the well-nourished and malnourished
patients, respectively (P = 0.007). The malnourished group
tended to experience multiple complications (P = 0.09).
Eighteen percent of patients exhibited one complication
(14 vs. 20% in well-nourished and malnourished groups),
10% of patients exhibited two complications (4 vs. 13% in
well-nourished and malnourished groups), 4% of patients
exhibited three complications (0 vs. 5% in well-nourished
and malnourished groups), 5% of patients exhibited four
complications (0 vs. 7% in well-nourished and malnour-
ished groups), and 2% of patients exhibited five complica-
tions (0 vs. 3% in well-nourished and malnourished groups).
Individual complications are given in Table 3.
In univariate analysis using logistic regression, malnutrition
measured with HGS according to Jamar (OR 4.3; CI:
1.4–12.9), CP score (OR 2.0; CI: 1.5–2.9), age (OR 1.03; CI:
0.99–1.07), and comorbidity (OR 0.56; CI: 0.23–1.37) were
variables with P-value < 0.2 when comparing patients with
and without complications during follow-up (Table 4). In
multivariate analysis with backward stepwise logistic
regression, malnutrition was an independent predictor of
complications, after correcting for age, comorbidity, and CP
score (adjusted OR 4.230; 95% CI: 1.09–16.4; P = 0.037).
Sensitivity, specificity, positive, and negative predicted
values of insufficient HGS to predict complications in our
cirrhotic group were 84, 44, 48, and 82%, respectively. When
comparing complication rates during the entire follow-up in
well versus malnourished patients for all CP classes, the two
curves were significantly different (log rank test,
P = 0.003; Fig. 1) and for the subgroup of patients with
CP class A compensated cirrhosis (log rank test, P = 0.016),
whereas differences did not reach statistical significance in
the subgroups with CP class B or C cirrhosis.
Mortality tended to be higher in the malnourished group
(4 vs. 18% in the well-nourished and malnourished
groups; P = 0.067). A Kaplan–Meier curve revealed a
nearly significant difference between the survival of well-
nourished and malnourished groups (P = 0.056, log rank
test). In univariate analysis, malnourishment tended to
Table 1 Baseline characteristics of 84 well-nourished and malnourished patients with cirrhosis based on Jamar hand-grip strength
All patients Well-nourished patients Malnourished patients P
Number of patients 84 28 56
Duration of follow-up (months) 13 ± 5 (1–19) 14 ± 3 (7–19) 12 ± 6 (1–19) 0.049
Etiology 0.462
Viral hepatitis 26 (31%) 10 (36%) 16 (29%)
Alcoholics 22 (26%) 5 (18%) 17 (30%)
Other 36 (43%) 13 (46%) 23 (41%)
Age (years) 55 ± 12 (22–79) 51 ± 13 (23–79) 56 ± 11 (22–77) 0.040
Sex (men) 56 (67%) 20 (71%) 36 (64%) 0.513
Child–Pugh class 0.047
A 49 (58%) 21 (75%) 28 (50%)
B 29 (35%) 7 (25%) 22 (39%)
C 6 (7%) 6 (11%)
Comorbidity 39 (46%) 10 (36%) 29 (52%) 0.164
On transplantation waiting list 24 (29%) 5 (18%) 19 (34%) 0.075
Routine blood tests
Bilirubin (mmol/l) 44 ± 95: 24 (3–845) 23 ± 14: 18 (7–61) 55 ± 115: 29 (3–845) 0.158
Protrombin activity (INR) 1.22 ± 0.22 (0.90–2.0) 1.15 ± 0.19 (0.96–1.8) 1.26 ± 0.23 (0.9–2.0) 0.066
Albumin (g/l) 35.8 ± 6.5 (20–49) 37.3 ± 5.2 (23.6–47.3) 34.5 ± 6.9 (20.4–49) 0.065
Creatinine (mmol/l) 88 ± 31 (43–247) 82 ± 17 (52–116) 91 ± 35 (43–247) 0.123
BMIc (% of patients with normal BMIc)a 25 ± 5 (16–40) (50%)a 25 ± 4 (19–37) (61%)a 26 ± 5 (16–40) (45%)a 0.684
Energy intake (kcal/day) 2058 ± 671 (694–4916) 2395 ± 651 (1181–4916) 1893 ± 622 (694–3978) 0.001
Sufficient 59% 74% 51% 0.045
Protein intake (g/day) 90 ± 31 (18–206) 110 ± 29:(72–206) 79 ± 27: (18–167) 0.000
Sufficient 46% 67% 36% 0.010
Energy % fat 33 ± 7 35 ± 7 32 ± 8 0.142
Energy % carbohydrates 50 ± 9 46 ± 6 52 ± 9 0.021
Energy % protein 17 ± 4 19 ± 3 16 ± 4 0.013
Ratio carbohydrate/protein intake (energy %) 3.1 ± 1.1: 3.0 (1.3–6.4) 2.6 ± 0.6:2.5 (1.5–3.8) 3.4 ± 1.2:3.2 (1.3–6.4) 0.002
Meal (number/day) 4.9 ± 1.3 (2–9) 4.9 ± 1.3 (2.5–7.5) 4.9 ± 1.3 (2–9) 0.717
Quality of life
Physical component summary 56 (8–98) 79 (34–98) 43 (8–95) 0.000
Mental component summary 64 (12–98) 74 (29–98) 59 (12–96) 0.066
Data are presented as n (%) or mean ± SD (range). In case of nonparametric distribution, medians (range) are also given. P-values for well-nourished vs.
malnourished group.
BMIc, body mass index corrected for fluid retention.
aPercentage of patients with normal BMIc.
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be associated with mortality (P = 0.1), but this trend was
lost in subsequent multivariate analysis.
Laboratory values at baseline and at end of follow-up in
the well-nourished and malnourished groups are given
in Table 5. Serum albumin levels decreased significantly
in both groups, whereas serum creatinine levels increased
significantly only in the malnourished group. At end of
follow-up, serum creatinine increased significantly more
from baseline values in the malnourished than in the well-
nourished group (increase + 2.39 vs. + 19.92mmol/l;
P = 0.04). Changes of serum bilirubin (increase at end of
follow-up from basal + 6.19mmol/l and + 12.84mmol/l in
well-nourished and malnourished groups, respectively),
albumin (decrease – 1.13 and – 2.17 g/l, respectively),
and prothrombin time (change from basal – 0.04 and
0.23, respectively) did not differ significantly between
well-nourished and malnourished groups.
Discussion
The main findings of this prospective study can be
summarized as follows: (a) there is a high prevalence of
malnutrition (25–70% depending on method of evalua-
tion) in patients with liver cirrhosis in the Netherlands,
Table 3 Complications and mortality during follow-up of 84 well-nourished and malnourished patients with cirrhosis based on Jamar hand-
grip strength
According to Jamar hand-grip strength
All patients Well-nourished patients Malnourished patients P
Number 84 28 56
Duration of follow-up (months) 13 ± 5 (1–19) 14 ± 3 (7–19) 12 ± 6 (1–19) 0.049
Complications at follow-up 32 (38%) 5 (18%) 27 (48%) 0.007
New onset ascites 20 (24%) 5 (18%) 15 (27%) 0.365
Hepatic encephalopathy 16 (19%) 0 16 (29%) 0.000
Esophageal bleeding 6 (7%) 0 6 (11%) 0.072
Hepatorenal syndrome 7 (8%) 0 7 (13%) 0.051
Spontaneous bacterial peritonitis 8 (10%) 0 8 (14%) 0.035
Other bacterial infections 11 (13%) 1 (4%) 10 (18%) 0.067
Hepatocellular carcinoma 4 (5%) 1 (4%) 3 (5%) 0.717
Mortality 11 (13%) 1 (4%) 10 (18%) 0.067
Data are presented as n (%) or mean ± SD (range).
Table 2 Nutritional intake and state in patients with cirrhosis according to Child–Pugh class
Child–Pugh class A Child–Pugh class B Child–Pugh class C P-value (two-sided)
Number 49 29 6
HGS
Jamar sufficient 21 (43%) 7 (21%) 0 (0%) 0.047*,**,***
Citec sufficient 15 (30%) 6 (21%) 1 (17%) 0.563
MAMC sufficient 21 (43%) 13 (45%) 1 (17%) 0.541
SGA sufficient 28 (57%) 7 (24%) 0 (0%) 0.002*,**,***
BCM sufficient 32 (67%) 17 (61%) 2 (33%) 0.278
BMIc (normal)a 25 ± 4 (18–37) (53%)a 26 ± 6 (16–40) (45%)a 24 ± 5 (16–32) (50%)a 0.311
Energy intake (kcal) 2200 ± 705 (833–4916) 1982 ± 461 (1087–2712) 1245 ± 630 (694–2133) 0.003**,***
Sufficient 74% 38% 17% 0.002*,**,***
Protein intake (g) 97 ± 32 (18–206) 81 ± 27 (37–141) 59 ± 18 (38–77) 0.014*,***
Sufficient 59% 28% 0 0.005*,**,***
Energy % fat 34 ± 7 32 ± 8 32 ± 7 0.522
Energy % carbohydrates 48 ± 8 52 ± 9 52 ± 11 0.238
Energy % protein 18 ± 3 16 ± 4 16 ± 4 0.232
Ratio carbohydrate/protein intake (energy %) 2.9 ± 0.93 (1.3–6.1) 3.4 ± 1.2 (1.8–6.4) 3.9 ± 1.4 (1.9–5.0) 0.023*
Fruit intake (pieces) 1.8 ± 1.7 (0–10) 1.5 ± 1.2 (0–5.5) 1.5 ± 1.0 (0–3) 0.706
Sufficient 47% 44% 20% 0.544
Vegetable intake (g) 106 ± 66 (0–270) 98 ± 76 (0–300) 30 ± 23 (0–50) 0.106
Sufficient 25% 22% 20% 0.946
Fiber (g) 25 ± 11 (8–64) 21 ± 7 (8–40) 15 ± 9 (8–28) 0.114
Sufficient 42% 22% 25% 0.216
Meal (number/day) 4.8 ± 1.3 (2–8) 5.2 ± 1.5 (3–9) 5.1 ± 1.5 (3–9) 0.297
Quality of life
Physical component summary 60 (9–98) 54 (8–96) 34 (12–96) 0.194
Mental component summary 66 (23–97) 56 (15–98) 43 (12–96) 0.257
Data are presented as n (%) or mean ± SD (range). P-value is calculated with one-way analysis of variance, Pearson w2 or Kruskall–Wallis test. With post-hoc test
(Fisher LSD).
BCM, body cell mass; BMIc, body mass index corrected for fluid retention; HGS, hand-grip strength; MAMC, mid-arm muscle circumference; SGA, subjective global
assessment.
*Significant difference (P < 0.05) for CP class A vs. B.
**For B vs. C.
***For A vs. C.
aPercentage of patients with normal BMIc.
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even in early stages of the disease; (b) risk of complica-
tions is significantly increased in case of malnutrition; (c)
intake of both energy and protein decreases progressively
with increasing disease severity according to CP class and
is associated with PEM. We evaluated PEM particularly
with Jamar HGS. Jamar HGS could be affected by
polyneuropathy, especially in alcoholic and diabetic
patients with cirrhosis. Although not significant, patients
with diabetes (11 of 13 patients) and alcoholic cirrhosis
(17 of 22 patients) tended to be overrepresented in the
malnourished group. Nevertheless, malnutrition accord-
ing to Jamar was associated with older age and higher CP
class but not with cause of underlying liver disease or
comorbidity (Tables 1 and 2). In addition, Jamar HGS
was an independent prognostic factor for complications
during follow-up in multivariate analysis, after adjusting
for several factors including comorbidity. In line with
other studies [19], Jamar HGS proved to be superior to
other anthropometric parameters of nutritional state to
predict complications. Differences in complication rates
between well-nourished and malnourished patients were
significant for the subgroup of patients with CP class A
compensated cirrhosis, but not for the subgroups with CP
class B or C cirrhosis. This phenomenon is not
unexpected: in patients with CP class B or C decom-
pensated cirrhosis, other factors than malnutrition such as
presence of ascites, bacterial overgrowth, and impaired
defence mechanisms against infection are probably
predominant in determining complication risk. In addi-
tion, the underlying mechanisms for the association
between nutritional state and certain complications such
as bacterial infections seem evident, whereas this is not
entirely clear for other complications such as variceal
bleeding. The prevalence of PEM among our Dutch
patients with decompensated cirrhosis in our study is
very similar to previous data from other countries [26]. Of
note, a significant proportion of our patients with
compensated cirrhosis also exhibited malnutrition, sug-
gesting nutritional deficiency in relatively early stages of
disease. Of special note, prevalence of overweight and
obesity (after correction for ascites, BMIc) were high in
our Dutch patients with liver cirrhosis, and independent
of CP class. Overweight and obesity are known risk
factors for development of cirrhosis [27]. Severe under-
weight was found in only 5% of Dutch patients, also
independent of CP class. The physical and mental
components of the quality of life (SF-36) tended to be
lower with increasing disease severity according to CP
class, without reaching significance. In contrast, the
physical component of the SF-36 was remarkably and
highly significantly lower in the malnourished patients
according to Jamar HGS. This suggests that malnutrition
according to Jamar HGS is associated with excessive
overall physical discomfort. The mental component of
the SF-36 also tended to be lower in the malnourished
group.
The decrease of energy and protein intake with increas-
ing CP class and in HGS insufficiency coincided with a
shift from protein to carbohydrate as reflected by
increasing ratio of carbohydrate/protein intake (energy
%). In contrast, fat intake (energy %) did not change
(see Tables 1 and 2). Despite the decrease in energy
intake, the BMIc did not differ between patients in the
three CP classes or between patients with sufficient or
insufficient HGS. Together, these findings suggest that
inadequate protein intake could explain, at least partly,
the high prevalence of PEM in our patients.
Our findings would suggest that dietary interventions
could improve PEM and might reduce complication rate.
Our findings also suggest that protein enrichment rather
than increased calorie intake per se should be emphasized
when counseling a patient with cirrhosis. Similarly, the
high prevalence of overweight we found, combined with a
high prevalence of insulin resistance found in general in
cirrhotics [28], indicates that only sufficient intake of
carbohydrates with a low glycemic load is wise in most
patients. It also leads us to suggest that protein
malnutrition (PM) rather than PEM could describe the
Fig. 1
log rank test: P = 0.003
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Complication-free survival is significantly lower in malnourished than in
well-nourished patients with cirrhosis according to Jamar hand-grip
strength test (log rank test, P = 0.003).
Table 4 Univariate analysis of various variables on occurrence of
new complications during follow-up in 84 patients with cirrhosis
New complications Mortality
OR 95% CI P OR 95% CI P
Hand-grip strength* 4.3 1.4–12.9 0.010 5.87 0.71–48.4 0.100
Age 1.03 0.99–1.07 0.169 1.08 1.01–1.16 0.022
Sex 1.88 0.71–4.98 0.207 1.22 0.28–5.28 0.795
Etiology 0.78 0.46–1.29 0.316 0.72 0.34–1.51 0.384
Comorbidity 0.56 0.23–1.37 0.200 2.24 0.6–8.33 0.228
CP score 2.04 1.45–2.86 0.000 2.07 1.38–3.1 0.000
BMIc 1.00 0.91–1.10 0.954 1.025 0.91–1.16 0.691
BMIc, body mass index corrected for fluid retention; 95% CI, 95% confidence
interval; CP, Child–Pugh; OR, odds ratio.
*According to Jamar.
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nutritional state in most patients with cirrhosis. Indeed,
nutritional interventions with protein-enriched supple-
ments have been shown to improve nutritional status and
nitrogen balance in cirrhotics [29,30]. Especially late-
evening supplements seem to be effective: in a recently
reported controlled trial, patients with cirrhosis were
randomized to either daytime or late evening adminis-
tration supplements (providing 26 g protein). There was a
highly significant improvement of total body protein
status in the late evening group, which was not the case
in the daytime group [29]. These interventions may
improve surrogate variables such as CP score, serum
albumin, and serum bilirubin and possibly mortality as
the most relevant clinical endpoint in patients with
cirrhosis [31]. Indeed, preoperative nutritional interven-
tion has been reported to reduce infection rates and
length of hospital stay after liver transplantation [32].
Quality of life may be influenced positively by nutritional
intervention as well [10]. It should also be realized that
nutrient intake and nutritional patterns play a key role in
genesis and progression of specific liver diseases (e.g.
alcoholic liver injury) [33]. Nevertheless, it should be
realized, that no prospective trials have unequivocally
demonstrated that nutritional intervention and protein-
enriched supplements could improve the course of
cirrhotic liver disease. In univariate analysis, malnourish-
ment tended to be associated with mortality (P = 0.1),
but this trend was lost in subsequent multivariate
analysis (see Results section). Apparently, malnourish-
ment was not an independent factor for mortality in this
study. This could relate to the possibility that other
factors (e.g. CP score) might be more prominent factors
for mortality and/or to the possibility that this study was
underpowered to detect an independent effect of
malnutrition on mortality.
Nevertheless, factors other than nutritional intake may
affect nutritional status in patients with cirrhosis as well.
Albumin synthesis seems to parallel liver function, that is
the more compromised the liver the less the albumin
production rate. Nevertheless, meal-induced albumin
synthesis is impaired even in compensated patients with
cirrhosis. Skeletal muscle protein synthesis is diminished
in cirrhosis and total muscle protein breakdown seems to
be increased, thus explaining the reduced muscle mass.
Specific degradation of myofibrillar protein may lead to
decreased muscle function as well [34,35]. Either
hormone or substrate resistance may be involved and
substances such as cytokines, insulin-like growth factor 1,
or leptin may play a role in the reduced synthesis of both
albumin and muscle proteins in liver cirrhosis [36].
Finally, the physical inactivity associated with severe liver
disease may also contribute to muscle wasting. It also
remains to be seen whether decreased HGS according to
Jamar signifies PM per se or is a more general parameter
for the severity of disease. In conclusion, we found a high
prevalence of PM in patients with cirrhosis even in the
early stages of disease. The prevalence of (often severe)
overweight was also high. PEM, as assessed by HGS
according to Jamar, was an independent predictor of
complications. Whether dietary counseling could reduce
PEM, overweight, and the high complication risk
associated with these conditions remains to be seen.
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